Abstract
Predictive medicine is a new philosophy in healthcare and an attractive subject for currently initiated research activities aimed at a potential application of innovative biotechnologies in the prediction of human pathologies, a development of well-timed prevention and individual therapy-planning. Diabetes care is one of the best examples of an absolute necessity for well-timed prediction, prevention and personalized treatment. Diabetes mellitus frequently results in diverse severe complications, such as retinopathy, nephropathy, silent ischemia, dementia, and cancer – the cascade of chronic complications appearing as “domino-effect”. Promising approaches of differential plasma proteome, detection of circulating nucleic acids and gene expression profiling in circulating leukocytes are currently discussed for development of potent diagnostic, prognostic and therapeutic targets. Minimal invasive insulin administration approaches and/or improvement of pancreatic activity in own insulin production is the main goal of novel drug delivery systems highly desirable for advanced treatment of diabetic patients with both type 1 and type 2 of the disease. High potential of an application of novel gene therapy approaches in diabetes care is expected for such advanced technologies as gene repair by gene replacement therapies.
Keywords: Metabolic syndrome, advanced technologies, novel targets, early / predictive diagnosis, drug delivery, gene therapy
Infectious Disorders - Drug Targets
Title: Diabetes Care: Risk Factors, Prediction, Prevention, and Individualized Treatment
Volume: 8 Issue: 2
Author(s): Olga Golubnitschaja
Affiliation:
Keywords: Metabolic syndrome, advanced technologies, novel targets, early / predictive diagnosis, drug delivery, gene therapy
Abstract: Predictive medicine is a new philosophy in healthcare and an attractive subject for currently initiated research activities aimed at a potential application of innovative biotechnologies in the prediction of human pathologies, a development of well-timed prevention and individual therapy-planning. Diabetes care is one of the best examples of an absolute necessity for well-timed prediction, prevention and personalized treatment. Diabetes mellitus frequently results in diverse severe complications, such as retinopathy, nephropathy, silent ischemia, dementia, and cancer – the cascade of chronic complications appearing as “domino-effect”. Promising approaches of differential plasma proteome, detection of circulating nucleic acids and gene expression profiling in circulating leukocytes are currently discussed for development of potent diagnostic, prognostic and therapeutic targets. Minimal invasive insulin administration approaches and/or improvement of pancreatic activity in own insulin production is the main goal of novel drug delivery systems highly desirable for advanced treatment of diabetic patients with both type 1 and type 2 of the disease. High potential of an application of novel gene therapy approaches in diabetes care is expected for such advanced technologies as gene repair by gene replacement therapies.
Export Options
About this article
Cite this article as:
Golubnitschaja Olga, Diabetes Care: Risk Factors, Prediction, Prevention, and Individualized Treatment, Infectious Disorders - Drug Targets 2008; 8 (2) . https://dx.doi.org/10.2174/187152608784746538
DOI https://dx.doi.org/10.2174/187152608784746538 |
Print ISSN 1871-5265 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3989 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Chromogranin A-Derived Vasostatins: New Players in the Endocrine Heart
Current Medicinal Chemistry Molecular Determinants of Vascular Calcification: A Bench to Bedside View
Current Molecular Medicine Current and Future Drugs for Appetite Regulation and Obesity Treatment
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Treatment of Hypertension in Heart Failure with Preserved Ejection Fraction
Current Hypertension Reviews Animal Models of Atherosclerosis Progression: Current Concepts
Current Drug Targets - Cardiovascular & Hematological Disorders An Association between MicroRNA-21 Expression and Vitamin D Deficiency in Coronary Artery Disease
MicroRNA Biomarkers in Lone Atrial Fibrillation-An Additional ‘Fine Tuning’ of Risk?
Current Pharmaceutical Design Current Therapeutic Strategies and Future Perspectives for the Prevention of Arterial Thromboembolism: Focus on Atrial Fibrillation
Current Pharmaceutical Design GCPII Imaging and Cancer
Current Medicinal Chemistry Ranolazine and its Antiarrhythmic Actions
Cardiovascular & Hematological Agents in Medicinal Chemistry Effects of Onion Extract on Endogenous Vascular H2S and Adrenomedulin in Rat Atherosclerosis
Current Pharmaceutical Biotechnology Proteomics of Biofilm Bacteria
Current Proteomics Impact of Ultrasound Contrast Agents in Echocardiographic Assessment of Ischemic Heart Disease
Recent Patents on Cardiovascular Drug Discovery Potential Treatment of Cardiac Hypertrophy and Heart Failure by Inhibiting the Sarcolemmal Binding of Phospholipase Cβ1b
Current Drug Targets Newer Oral Anticoagulant Agents: A New Era in Medicine
Current Cardiology Reviews Polyphenols and Aging
Current Aging Science Antiplatelet Therapy in TAVI: Current Clinical Practice and Recommendations
Current Pharmaceutical Design Involvement of Gaucher Disease Mutations in Parkinson Disease
Current Protein & Peptide Science Current Progress of Lipid Analysis in Metabolic Diseases by Mass Spectrometry Methods
Current Medicinal Chemistry Multifaceted Synthesis, Properties and Applications of Polyurethanes and its Composites
Current Organic Chemistry